Toxoplasma gondii inhibits mast cell degranulation by suppressing phospholipase Cγ-mediated Ca(2+) mobilization

Norah L Smith1, Delbert S Abi Abdallah, Barbara A Butcher

  • 1Baker Laboratory, Department of Chemistry and Chemical Biology, Cornell University Ithaca, NY, USA.

Insights

Toxoplasma gondii infection impairs immune cell signaling by blocking calcium responses and kinase activation. This immune subversion begins during parasite invasion, affecting crucial cellular communication pathways.

Area of Science:

  • Immunology
  • Cell Biology
  • Parasitology

Background:

  • Toxoplasma gondii is known to evade host immune responses, but the precise mechanisms, especially concerning calcium signaling, remain unclear.
  • Altered receptor-activated calcium (Ca2+) mediated signaling is a key aspect of immune evasion by pathogens.
  • Previous findings indicated T. gondii infection inhibits Ca2+ responses in macrophages.

Purpose of the Study:

  • To investigate how T. gondii modulates IgE receptor-activated signaling in RBL mast cells within the first hour of infection.
  • To elucidate the mechanism by which T. gondii inhibits Ca2+ mobilization and subsequent cellular responses.
  • To determine if the inhibition is strain-dependent and linked to the invasion process.

Main Methods:

  • Utilized the RBL mast cell model to study IgE/FcεRI signaling pathways.
  • Measured Ca2+ mobilization and antigen-stimulated degranulation in infected versus uninfected cells.
  • Assessed the activation of Syk kinase and phospholipase Cγ (PLCγ) phosphorylation.
  • Investigated the effect of inhibiting tachyzoite invasion (cytochalasin D) on signaling inhibition.

Main Results:

  • T. gondii infection significantly inhibited antigen-stimulated degranulation in mast cells in a strain-independent manner.
  • Infected cells showed reduced cytoplasmic Ca2+ mobilization, particularly release from intracellular stores.
  • The study observed inhibition of Syk kinase activation, tyrosine phosphorylation, and PLCγ activation.
  • Signaling inhibition persisted even when parasite invasion was blocked, suggesting a secreted factor is involved.

Conclusions:

  • T. gondii actively inhibits IgE/FcεRI signaling cascades in mast cells.
  • The parasite likely achieves this by secreting a factor that interferes with tyrosine kinase signaling, reducing phosphatidylinositol 4,5-bisphosphate hydrolysis.
  • Immune subversion by T. gondii commences during the invasion process, impacting critical host cell signaling pathways early on.

Related Concept Videos

GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...